Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia
Journal of Oncology Pharmacy Practice
Published online on April 21, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
Introduction:Patients with acute myeloid leukemia (AML) are immunocompromised as a result of their malignancy and treatment, which can predispose to infection. The incidence of bacterial infection is most common (75–80%), followed by fungal (7–33%) and ...
Introduction:Patients with acute myeloid leukemia (AML) are immunocompromised as a result of their malignancy and treatment, which can predispose to infection. The incidence of bacterial infection is most common (75–80%), followed by fungal (7–33%) and ...